{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:02:26Z","timestamp":1779890546384,"version":"3.53.1"},"reference-count":35,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Transdisciplinary Research Grant Scheme","award":["TRGS\/1\/2022\/UKM\/02\/8\/3"],"award-info":[{"award-number":["TRGS\/1\/2022\/UKM\/02\/8\/3"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,13]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This national study assessed the economic impact of treating patients with antimicrobial resistance (AMR) pathogens within Malaysia\u2019s Ministry of Health (MoH) hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A cross-sectional study design and top-down costing approach, analysing Malaysian diagnosis-related group (DRG) data for AMR patients admitted to MoH hospitals from 2017 to 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and participants<\/jats:title>\n                    <jats:p>A total of 1190 cases were identified using International Statistical Classification of Diseases-10 version 2010 codes for AMR pathogens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>The study aims to estimate direct healthcare costs for treating AMR patients. Costs per admission were calculated based on each patient\u2019s length of stay (LOS). A binary logistic regression model identified cost determinants, with significant factors (p&lt;0.05) further analysed using a multivariate multiple logistic regression. ORs with 95% CIs were determined, and treatment costs were categorised as above or below the annual national base rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Findings showed that costs are influenced by the volume of cases identified through DRG codes and LOS, which averaged between 21.7 and 36.4\u2009days. Median admission costs for AMR patients ranged from RM12 476.28 (IQR RM 15 655.93) to RM19 295.11 (IQR RM20 200.28). Both LOS and total costs increased annually, from RM3 711 046.10 in 2017 to RM9 700 249.08 in 2019. Patients over 56 years old and those with severity levels II and III were more likely exceeding the national base rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings, explaining 9.3% of the variance in the regression model, can inform policies to reduce the economic burden of AMR and improve patient outcomes, highlighting the need for a comprehensive strategy to address this global health threat.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-091687","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:15:34Z","timestamp":1739452534000},"page":"e091687","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Antimicrobial resistance in Malaysia: a cross-sectional study analysing trends and economic impacts"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-1380","authenticated-orcid":false,"given":"Muhammad Nur Amir","family":"AR","sequence":"first","affiliation":[{"name":"Department of Public Health Medicine, National University of Malaysia Faculty of Medicine, Cheras, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifa Ezat","family":"Binti Wan Puteh","sequence":"additional","affiliation":[{"name":"Department of Public Health Medicine, National University of Malaysia Faculty of Medicine, Cheras, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-5970","authenticated-orcid":false,"given":"Roszita","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Public Health Medicine, National University of Malaysia Faculty of Medicine, Cheras, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Mizanur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Community Medicine and Public Health, University of Malaysia Sarawak, Sarawak, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulkefly","family":"Abdul Karim","sequence":"additional","affiliation":[{"name":"Centre for Sustainable and Inclusive Development Studies (SID), National University of Malaysia Faculty of Economic and Management, Bangi, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi Zaidan","family":"Bin Ali","sequence":"additional","affiliation":[{"name":"Hospital Management Services Unit, Medical Services Development Branch, Medical Development Division, Ministry of Health Malaysia, Putrajaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Farah","family":"Binti Bakhtiar","sequence":"additional","affiliation":[{"name":"Medical Care Quality Branch, Medical Development Division, Ministry of Health Malaysia, Putrajaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2025121602400295000_15.2.e091687.1","unstructured":"O\u2019Neill J . Tackling drug-resistant infections globally: final report and recommendations, Government of the United Kingdom. 2016. Available: https:\/\/apo.org.au\/sites\/default\/files\/resource-files\/2016-05\/apo-nid63983.pdf"},{"key":"2025121602400295000_15.2.e091687.2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S234610"},{"key":"2025121602400295000_15.2.e091687.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-1507-2","article-title":"Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies","volume":"18","author":"Jit","year":"2020","journal-title":"BMC Med"},{"key":"2025121602400295000_15.2.e091687.4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-07142-2","article-title":"Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study","volume":"12","author":"Tan","year":"2022","journal-title":"Sci Rep"},{"key":"2025121602400295000_15.2.e091687.5","unstructured":"Medical Development Division, Ministry of Health Malaysia . MalaysianDRG framework. 2021. Available: https:\/\/www.moh.gov.my\/"},{"key":"2025121602400295000_15.2.e091687.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201609-1848OC"},{"key":"2025121602400295000_15.2.e091687.7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac133","article-title":"The Increased Length of Hospital Stay and Mortality Associated With Community-Associated Infections in Australia","volume":"9","author":"Wozniak","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025121602400295000_15.2.e091687.8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ajic.2015.01.031","article-title":"Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care","volume":"43","author":"Thampi","year":"2015","journal-title":"Am J Infect Control"},{"key":"2025121602400295000_15.2.e091687.9","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-018-0336-y","article-title":"Estimating the burden of antimicrobial resistance: a systematic literature review","volume":"7","author":"Naylor","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025121602400295000_15.2.e091687.10","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11091186","article-title":"Educational Interventions to Reduce Prescription and Dispensing of Antibiotics in Primary Care: A Systematic Review of Economic Impact","volume":"11","author":"Rocha","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2025121602400295000_15.2.e091687.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117710","article-title":"Systematic review on irrational use of medicines in China and Vietnam","volume":"10","author":"Mao","year":"2015","journal-title":"PLoS ONE"},{"key":"2025121602400295000_15.2.e091687.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297921","article-title":"Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries","volume":"19","author":"Ajulo","year":"2024","journal-title":"PLoS ONE"},{"key":"2025121602400295000_15.2.e091687.13","unstructured":"Medical Development Division, Ministry of Health Malaysia . Specialty & Subspecialty Framework of Ministry of Health Hospitals under 11th Malaysia Plan (2016-2020). 2016. Available: http:\/\/www.moh.gov.my"},{"key":"2025121602400295000_15.2.e091687.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.17.46.20316-en","article-title":"The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use","volume":"17","author":"Zarb","year":"2012","journal-title":"Euro Surveill"},{"key":"2025121602400295000_15.2.e091687.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.04.004"},{"key":"2025121602400295000_15.2.e091687.16","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-018-0644-7","article-title":"Pediatric Antimicrobial Stewardship: State of the Art","volume":"20","author":"Godbout","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"2025121602400295000_15.2.e091687.17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jpids\/piw093","article-title":"Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015","volume":"7","author":"Meropol","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025121602400295000_15.2.e091687.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jacamr\/dlac128","article-title":"Variation in antibiotic resistance patterns for children and adults treated at 166 non-affiliated US facilities using EHR data","volume":"5","author":"Sivasankar","year":"2022","journal-title":"JAC-Antimicrobial Resistance"},{"key":"2025121602400295000_15.2.e091687.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0\/ATTACHMENT\/4504FC2B-08AE-46D6-BD75-80811DF8B5E6\/MMC1.PDF"},{"key":"2025121602400295000_15.2.e091687.20","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piy018"},{"key":"2025121602400295000_15.2.e091687.21","unstructured":"WHO . Global Health Expenditure Database, Available: https:\/\/apps.who.int\/nha\/database"},{"key":"2025121602400295000_15.2.e091687.22","unstructured":"World Health Organization, Regional Office for the Western Pacific . Health and economic impacts of antimicrobial resistance in the Western Pacific Region, 2020\u20132030. 2023. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/368654\/9789290620112-eng.pdf?sequence=5&isAllowed=y"},{"key":"2025121602400295000_15.2.e091687.23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01041-09"},{"key":"2025121602400295000_15.2.e091687.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-099(18)30605-4"},{"key":"2025121602400295000_15.2.e091687.25","doi-asserted-by":"publisher","DOI":"10.1179\/2047773215Y.0000000030"},{"key":"2025121602400295000_15.2.e091687.26","first-page":"83","article-title":"The MalaysianDRG Casemix System: Financial Implications of Inaccurate Clinical Documentation and Coding Error","volume":"17","author":"Saizan","year":"2021","journal-title":"Malaysian J Med Heal Sci"},{"key":"2025121602400295000_15.2.e091687.27","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0242-y"},{"key":"2025121602400295000_15.2.e091687.28","unstructured":"Health Informatics Centre, Planning Division, Ministry of Health Malaysia . Health Informatics Centre, Planning Division, Ministry of Health Malaysia. Health Facts 2024. 2024. Available: https:\/\/www.moh.gov.my\/"},{"key":"2025121602400295000_15.2.e091687.29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2044.1998.00615.x"},{"key":"2025121602400295000_15.2.e091687.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285170","article-title":"The economic burden of antibiotic resistance: A systematic review and meta-analysis","volume":"18","author":"Poudel","year":"2023","journal-title":"PLoS ONE"},{"key":"2025121602400295000_15.2.e091687.31","unstructured":"World Health Organization . Antimicrobial Resistance, 2023. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"2025121602400295000_15.2.e091687.32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44272-1","article-title":"Convergence of resistance and evolutionary responses in Escherichia coli and Salmonella enterica co-inhabiting chicken farms in China","volume":"15","author":"Baker","year":"2024","journal-title":"Nat Commun"},{"key":"2025121602400295000_15.2.e091687.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-021-00936-5","article-title":"Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia","volume":"10","author":"Ngoi","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025121602400295000_15.2.e091687.34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s42256-024-00809-7","article-title":"Generative AI for designing and validating easily synthesizable and structurally novel antibiotics","volume":"6","author":"Swanson","year":"2024","journal-title":"Nat Mach Intell"},{"key":"2025121602400295000_15.2.e091687.35","doi-asserted-by":"publisher","DOI":"10.1086\/323758"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-091687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:40:13Z","timestamp":1765881613000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-091687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,13]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-091687"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-091687","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}